Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q35688259

about

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.Cardiovascular risk assessment in patients with diabetes.Nonalcoholic fatty liver disease and cardiovascular disease Nonalcoholic fatty liver disease and the heart in children and adolescents.Links between ectopic fat and vascular disease in humans Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.Gender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individuals Association of adiponectin gene polymorphism with nonalcoholic fatty liver disease in Taiwanese patients with type 2 diabetes.Non-alcoholic fatty liver disease - the heart of the matter Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Pericardial- Rather than Intramyocardial Fat Is Independently Associated with Left Ventricular Systolic Heart Function in Metabolically Healthy Humans.Right ventricular function and its relationship with grade of hepatosteatosis in non-alcoholic fatty liver disease.Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?Brain Natriuretic Peptide in Liver Cirrhosis and Fatty Liver: Correlation with Cardiac Performance.Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.Quercetin Isolated from Toona sinensis Leaves Attenuates Hyperglycemia and Protects Hepatocytes in High-Carbohydrate/High-Fat Diet and Alloxan Induced Experimental Diabetic Mice.Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease Non-alcoholic fatty liver disease-From the cardiologist perspective.Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography.Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.Mechanisms of adverse cardiometabolic consequences of obesity.Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis Intracellular lipid accumulation and shift during diabetes progression.Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.Is hepatic steatosis associated with left ventricular mass index increase in the general population?Role of Epicardial Adipose Tissue in Health and Disease: A Matter of Fat?Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Heart, lipids and hormones.Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.Bone mineral density is associated with left ventricular diastolic function in women.Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus

P2860

Q26798155-449878C4-AF38-4FF8-84FD-4F8435F7D944 Q27692035-DC02FD37-708B-456C-8616-2ED817613863 Q33582582-E4B90EF2-5055-4139-9241-6A17DDDBB536 Q33886952-FA09D766-DEF7-4D48-8C21-7F8A3DD1DCEB Q33958722-CF75BF33-A25B-4419-BD2D-07AD823BE15B Q34076155-B950AC29-800F-4804-980F-EABE73392828 Q34603226-82EB71B1-1F98-4CDC-AA5D-7199067FC017 Q34998991-2C560448-507D-4269-B5DB-0EEDA805FDB8 Q35088712-E7595692-8190-487B-BCA8-3D7A2F601223 Q35558556-33397F16-AB09-4B9C-BCE8-AF8D7B9A55C5 Q35652518-A142BDD3-5F13-4E00-B118-084B30507DEF Q35668765-8C6B21E4-6D8C-42CF-8A9E-F8AC900C79D4 Q35740071-81F8774B-2158-41C2-919E-9602FD5506E0 Q35841934-60BF529B-2D84-49E1-9C6E-C7F67D3E12AF Q35953956-9DD1C55F-BF52-4AB9-A76C-5D5752A7D423 Q35962132-353A494F-890C-421A-B27D-2AA12E627D53 Q35995660-AC16DF6D-A962-473B-AAD5-BC106AB34D98 Q36520139-E180D495-6C1A-404F-94CF-A033DB855FA3 Q36766666-809A039B-631B-4929-84F8-831ED8FAB8E8 Q37002532-24092786-7A62-477B-8AAC-43519C1BDAD6 Q37375539-AE8A6528-D8D1-4D68-BAC3-93E32D7EA48F Q37385527-FA1F82BA-2D29-4D03-BA90-44881B620D3F Q37448581-A9F6873B-E161-4CAD-A718-EE9A79FD1E0B Q37548563-E931DB89-DFD1-4EA6-BBF9-211CEC3751AE Q37596189-4A58B576-9E69-400B-BEF8-E2B80E55DAF1 Q37672952-F0341D2D-FF74-4F89-BF69-A3B71E99E297 Q37680608-5E8322A5-7555-44B8-B14D-8FA0E0DBFF9F Q38008136-493AEF76-2F97-4AD6-B013-0592DA7E7F49 Q38139270-19CF3F87-F4F3-4FCF-97ED-1C60D9EA2D69 Q38197613-6E560353-A5AB-46CE-9E05-73B260712611 Q38232287-B21592AD-696C-4BAF-A4B6-16C01551BBFF Q38397177-A3E89FE4-EA38-433D-B252-11C5157778B5 Q38663332-8B4A1B12-1786-48CD-BFA3-9B9708E2A711 Q38668014-357216B2-C8D3-410B-947A-31705DCD7FD7 Q38711424-49A8F82E-BDFE-4DFD-BEA3-C4255D63D4AF Q39249408-361ACB78-7712-4CCA-BBCB-93DD4F0BCAED Q40218239-4E9B9DED-9256-4DA0-A841-6DBF0CF44007 Q40550177-55C3E2B9-9852-44FF-B23C-A9FF4DFB6F6B Q41485370-94C0A01A-3BEE-46E8-86C5-CAD88886B833 Q42370713-D1BE127E-9C1F-4483-9C25-82B0A336FCF5

P2860

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q35688259

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@ast

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@en

type

label

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@ast

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@en

prefLabel

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@ast

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@en

P1433

Q35688259-CF52AAE6-F7A7-4E1D-9885-2965E1E4D83F

P1476

Q35688259-2B0F80ED-A1E0-4833-A720-989E07CCE80C

P2093

Q35688259-0DD8CDC1-5EF9-42D7-9475-8B177748DD43

Q35688259-274ED600-4B2B-4C01-94BD-0BA69E22FE07

Q35688259-4D371BF3-AFA5-41C4-AB5B-6C2DABE1CC63

Q35688259-7004C89A-5BBC-4A38-B8A0-DEDBAA0B90AB

Q35688259-75E5F26C-B480-4844-B17C-A17E481C79C2

Q35688259-F6D19CCC-C784-4F98-BFA8-925FED94761C

P2860

Q35688259-05A35B0F-A72C-49EA-B5FE-44FB530F7A21

Q35688259-06884374-DC1A-4C28-8233-5DD9C23F5842

Q35688259-0F959D77-7608-4054-B476-EF153547EA36

Q35688259-154C5584-0E94-4247-99D4-89CBE52C8431

Q35688259-15FCAAA7-3D35-4860-8395-A8AC33F26D33

Q35688259-1DFD945E-499F-4782-BA68-DBCCC761B21F

Q35688259-268BDFF4-7C03-44A7-B91E-3E0D9AFCB47A

Q35688259-29515B19-EF91-4B40-B44F-9D170D6E6E02

Q35688259-2AD097CD-CD06-45DC-A836-E6933B897C7F

Q35688259-2FC0AFC3-333E-4BB4-82AD-22949F15A0D4

P304

Q35688259-BFAE0274-70DF-419C-AA30-9179CA21397C

P31

Q35688259-D6E28DE2-C146-469A-A699-692F48964537

P356

Q35688259-AED7FDCD-F861-4D25-A7B9-8EDEF46C0080

P407

Q35688259-FCAA4788-C76B-444F-A4FE-EAE494FE8516

P433

Q35688259-F31D2ED5-37F6-494A-A4F0-D8B2BFBA764C

P478

Q35688259-4826A2B8-B346-40EA-B4BC-3D20F58BDF89

P50

Q35688259-4DF61AC0-9903-482E-8CE0-1236FAEB4339

Q35688259-937D4582-DC4A-4456-BECA-71DAAA2814D4

P577

Q35688259-2D01896F-1A72-4517-A29A-ED83054FB595

P5875

Q35688259-714E2B2B-9AFE-4AC1-BC00-A37489E564E2

P698

Q35688259-DB676747-96C4-422F-A989-6C4CAC5E308B

P921

Q35688259-CCC73905-C8CA-4F79-B835-8D14F628D33F

Q35688259-E1699CCD-830C-4094-8739-AFC35E09508A

P932

Q35688259-6F24C7EE-78F2-430F-84AB-D6C837CC9CB5

P356

P1433

P1476

Nonalcoholic fatty liver disea ...... patients with type 2 diabetes.

@en

P2093

Enrico Barbieri

http://www.w3.org/2001/XMLSchema#string

Giacomo Zoppini

http://www.w3.org/2001/XMLSchema#string

Giovanni Targher

http://www.w3.org/2001/XMLSchema#string

Giulio Molon

http://www.w3.org/2001/XMLSchema#string

Guido Canali

http://www.w3.org/2001/XMLSchema#string

Lorenzo Bertolini

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis.

Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.

Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Standards of medical care in diabetes--2011.

Recommendations for chamber quantification.

P304

389-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-1820

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Bonapace

Gianluca Perseghin

P577

2011-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51973888

http://www.w3.org/2001/XMLSchema#string

P698

22210573

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3263884

http://www.w3.org/2001/XMLSchema#string